Atara Biotherapeutics (ATRA) FCF Margin Growth (3y) (2024 - 2026)
Atara Biotherapeutics (ATRA) FCF Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4,612.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 14,060.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -3,088.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1,850.00 |
| 10 | Atara Biotherapeutics | 140.71 Mn | 124.16 Mn | 439,000.00 | 503,912.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 503,912.00 |
| Mar 31, 2026 | 377,358.00 |
| Dec 31, 2025 | 285,241.00 |
| Sep 30, 2025 | 117,339.00 |
| Jun 30, 2025 | 7,758.00 |
| Dec 31, 2024 | 38,275.00 |
| Sep 30, 2024 | 104,367.00 |
| Jun 30, 2024 | 160,668.00 |
| Mar 31, 2024 | 180,322.00 |